Figure 6.
Altered DAPK2 expression and Akt activation in Lyn-/-erythroblasts. (A) Lyn-/- and wild-type erythroblasts were expanded from bone marrow preparations in SP34-EX media to yield 90% or more CD71high populations. Kitpos erythroblasts were isolated via MACS, washed, deprived of cytokines for 6 hours, and then exposed to SCF plus Epo (150 ng/mL, 5 U/mL) for the indicated intervals. Levels of DAPK2 in KitposCD71high cells then were assayed by Western blotting and quantitatively by densitometry (bottom panels). (B) Lyn-/- and wild-type erythroblasts were expanded from bone marrow preparations in SP34-EX media, and KitposCD71high erythroblasts were isolated. Cells were then washed and cultured in the absence of SCF and Epo. At the indicated intervals of subsequent exposure to SCF plus Epo (150 ng/mL, 5 U/mL), levels of phospho-Akt were determined. In repeated independent experiments, KitnegCD71high erythroblasts also were analyzed (together with KitposCD71high cells) (Figure S4).